Krause Kevin Michael Insider Trades

Insider Trading History

Track insider trading activity for Krause Kevin Michael. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
AN2 Therapeutics
AN2 Therapeutics ANTX
Chief Strategy Officer
Holding Value $250k 60,000 shares
Last Trade
Mar 15, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$180k 60,000 shares
$3.00
$4.17
AN2 Therapeutics
AN2 Therapeutics ANTX
Chief Strategy Officer
Holding Value $38.9k 9,331 shares
Last Trade
Jan 09, 2024 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$160k 7,417 shares
$21.53
$4.17
AN2 Therapeutics
AN2 Therapeutics ANTX
Chief Strategy Officer
Holding Value $208k 49,868 shares
Last Trade
Jan 09, 2024 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$160k 7,417 shares
$21.53
$4.17
AN2 Therapeutics
AN2 Therapeutics ANTX
Chief Strategy Officer
Holding Value $7.98k 1,914 shares
Last Trade
Jan 09, 2024 Sale (Open Market)Shares sold on the open market or in a private sale.
$149k 7,417 shares
$20.14
$4.17
AN2 Therapeutics
AN2 Therapeutics ANTX
Chief Strategy Officer
Holding Value $218k 52,285 shares
Last Trade
Jan 02, 2024 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$51.3k 2,583 shares
$19.87
$4.17
AN2 Therapeutics
AN2 Therapeutics ANTX
Chief Strategy Officer
Holding Value $18.8k 4,497 shares
Last Trade
Jan 02, 2024 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$51.3k 2,583 shares
$19.87
$4.17
AN2 Therapeutics
AN2 Therapeutics ANTX
Chief Strategy Officer
Holding Value $7.98k 1,914 shares
Last Trade
Jan 02, 2024 Sale (Open Market)Shares sold on the open market or in a private sale.
$52k 2,583 shares
$20.12
$4.17
AN2 Therapeutics
AN2 Therapeutics ANTX
Chief Strategy Officer
Holding Value $259k 62,200 shares
Last Trade
Feb 15, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$889k 62,200 shares
$14.29
$4.17
AN2 Therapeutics
AN2 Therapeutics ANTX
Chief Strategy Officer
Holding Value $275k 66,000 shares
Last Trade
May 12, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.14M 66,000 shares
$17.28
$4.17
AN2 Therapeutics
AN2 Therapeutics ANTX
Chief Strategy Officer
Holding Value $0 0 shares
Last Trade
Mar 24, 2022 Sale
No data
No data
$4.17

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up